POSSIBLE MUTATION PATHWAYS IN SARS-CoV-2

Basit Öğe Kaydı
dc.authoridCalina, Daniela/0000-0002-1523-9116
dc.authoridMartorell, Miquel/0000-0003-3183-7623
dc.authoridCruz-Martins, Natalia/0000-0002-5934-5201
dc.authoridSharifi-Rad, Javad/0000-0002-7301-8151
dc.authoridDocea, Anca Oana/0000-0002-8162-5955
dc.authoridKumar, Manoj/0000-0002-4192-6497
dc.contributor.authorIslam, Muhammad Torequl
dc.contributor.authorQuispe, Cristina
dc.contributor.authorHerrera-Bravo, Jesus
dc.contributor.authorKhan, Ishaq N.
dc.contributor.authorBawazeer, Saud Salem
dc.contributor.authorKumar, Manoj
dc.contributor.authorCruz-Martins, Natalia
dc.date.accessioned2024-10-26T18:11:43Z
dc.date.available2024-10-26T18:11:43Z
dc.date.issued2021
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractMutations are the best way to generate genetic variation, as they provide the raw material in which evolutionary forces, like natural selection, can act. However, mutations are not always able to change the apparent behaviour of an organism, instead, they are capable of providing normal and abnormal biological functions. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered a new and controversial biological scenario. Despite the hundreds of studies performed, to date, there is no specific treatment available. Several genomic and non-genomic mutations have been also reported, and due to its high genome size and mutation capacity, it can acclimatize to variable environments and has become the leading cause of high infection and mortality rates. This review outlines the possible pathways behind SARS-CoV-2 mutations.
dc.identifier.doi10.31925/farmacia.2021.6.1
dc.identifier.endpage1017
dc.identifier.issn0014-8237
dc.identifier.issn2065-0019
dc.identifier.issue6
dc.identifier.scopus2-s2.0-85122081796
dc.identifier.scopusqualityQ2
dc.identifier.startpage1001
dc.identifier.urihttps://doi.org/10.31925/farmacia.2021.6.1
dc.identifier.urihttps://hdl.handle.net/20.500.12418/30772
dc.identifier.volume69
dc.identifier.wosWOS:000734305000001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherSoc Stiinte Farmaceutice Romania
dc.relation.ispartofFarmacia
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectSARS-CoV-2
dc.subjectmutations
dc.subjectorigin
dc.subjecttransmission
dc.subjectvirulence
dc.subjectgenetic diversity
dc.subjectvaccines
dc.titlePOSSIBLE MUTATION PATHWAYS IN SARS-CoV-2
dc.typeReview Article

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu